Clinical Trial

Probiotics in Advanced Urothelial Carcinoma

Name: Probiotics in Advanced Urothelial Carcinoma — clinical trial record (NCT06904573)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: IMPROVE

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a multicenter, randomized, controlled phase II Study of evaluating the efficacy and safety of immunotherapy combined with probiotics compound (Biolosion) in patients with advanced urothelial carcinoma.

Trial Details

NCT Number	NCT06904573
Lead Sponsor	Sun Yat-sen University
Conditions	Advanced Urothelial Carcinoma, Probiotics, Immunotherapy
Enrollment	222 participants
Start Date	2025-01-01
Primary Completion	2027-01-01 (estimated)
Study Completion	2028-01-01 (estimated)
Updated on ClinicalTrials.gov	2025-04-01